rs193922365
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_000218.3(KCNQ1):c.905C>A(p.Ala302Glu) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A302T) has been classified as Pathogenic.
Frequency
Consequence
NM_000218.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KCNQ1 | ENST00000155840.12 | c.905C>A | p.Ala302Glu | missense_variant | Exon 6 of 16 | 1 | NM_000218.3 | ENSP00000155840.2 | ||
KCNQ1 | ENST00000335475.6 | c.524C>A | p.Ala175Glu | missense_variant | Exon 6 of 16 | 1 | ENSP00000334497.5 | |||
KCNQ1 | ENST00000496887.7 | c.644C>A | p.Ala215Glu | missense_variant | Exon 7 of 16 | 5 | ENSP00000434560.2 | |||
KCNQ1 | ENST00000646564.2 | c.478-10465C>A | intron_variant | Intron 2 of 10 | ENSP00000495806.2 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD4 exome Cov.: 32
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Long QT syndrome Pathogenic:2
This sequence change replaces alanine, which is neutral and non-polar, with glutamic acid, which is acidic and polar, at codon 302 of the KCNQ1 protein (p.Ala302Glu). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individuals with long QT syndrome (PMID: 19716085; Invitae). ClinVar contains an entry for this variant (Variation ID: 67121). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt KCNQ1 protein function with a positive predictive value of 95%. This variant disrupts the p.Ala302 amino acid residue in KCNQ1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 17905336, 19808498, 25786344, 27917693). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
This missense variant replaces alanine with glutamic acid at codon 302 of the KCNQ1 protein. Computational prediction suggests that this variant may have deleterious impact on protein structure and function (internally defined REVEL score threshold >= 0.7, PMID: 27666373). This variant is found within a highly conserved pore-forming region (a.a. 300-320). Rare nontruncating variants in this region have been shown to be significantly overrepresented in individuals with long QT syndrome (PMID: 32893267). To our knowledge, functional studies have not been reported for this variant. This variant has been reported in at least four unrelated individuals affected with long QT syndrome (PMID: 26318259, 26669661, ClinVar: SCV000817627.3, SCV000234432.9), and in an individual suspected of having long QT syndrome (PMID: 19716085). It has been shown that this variant segregates with disease in two of the families (PMID: 26669661, ClinVar SCV000234432.9). This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). A different missense variant occurring at the same codon, p.Ala302Val, is known to be disease-causing (ClinVar variation ID: 36439), indicating that alanine at this position is important for KCNQ1 protein function. Based on the available evidence, this variant is classified as Likely Pathogenic. -
not provided Pathogenic:1
p.Ala302Glu (GCG>GAG): c.905 C>A in exon 6 of the KCNQ1 gene (NM_000218.2). The Ala302Glu mutation in the KCNQ1 gene has been reported in one individual with LQTS and absent from 2,600 control alleles (Kapplinger J et al., 2009). Ala302Glu results in a non-conservative amino acid substitution of a non-polar Alanine with a negatively charged Glutamic acid at a position that is conserved across species. Other mutations at this residue (Ala302Thr, Ala302Val) and nearby residues (Ala300Thr, Leu303Pro) have been reported in association with LQTS, further supporting the functional importance of this codon and this region of the protein. Furthermore, Ala302Glu was not observed in approximately 6,500 individuals of European and African American ancestry in the NHLBI Exome Sequencing Project, indicating it is not a common benign variant in these populations. The variant is found in LQT panel(s). -
Cardiovascular phenotype Pathogenic:1
The p.A302E variant (also known as c.905C>A), located in coding exon 6 of the KCNQ1 gene, results from a C to A substitution at nucleotide position 905. The alanine at codon 302 is replaced by glutamic acid, an amino acid with dissimilar properties. This variant was identified in one individual undergoing genetic testing for long QT syndrome (Kapplinger JD et al. Heart Rhythm, 2009 Sep;6:1297-303). This amino acid position is highly conserved in available vertebrate species. In addition, this alteration is predicted to be deleterious by in silico analysis. Another variant, p.A302, has been described in the same codon in trans with a second KCNQ1 alteration in an individual with Jervell and Lange-Nielsen syndrome and alone in individuals with long QT syndrome (Wang C et al. Acta Otolaryngol., 2017 May;137:522-528; Tester DJ et al. Heart Rhythm, 2005 May;2:507-17; Chung SK et al. Heart Rhythm, 2007 Oct;4:1306-14; Olesen MS et al. Heart Rhythm, 2014 Feb;11:246-51). Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Congenital long QT syndrome Other:1
This variant has been reported as associated with Long QT syndrome in the following publications (PMID:19716085). This is a literature report, and does not necessarily reflect the clinical interpretation of the Imperial College / Royal Brompton Cardiovascular Genetics laboratory. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at